Slide 1
PharmEvo (Private) Limited, 402, Business Avenue, Block-6, P.E.C.H.S., Shahrah-e-Faisal, Post Box 3156, Karachi-75400 PAKISTAN.Tele. (+92-21) 3431 5195-7, 3455 6330, Fax: (+92-21) 3455 6344Our Dream A Healthier Society PharmEvo
Total Area:803,940 SQ. KMProvinces:5Cities:105
Population:181 MILLION Male:51%Female:49%Population Growth:2.03 % P.A.
Life ExpectancyMale:64 YEARSFemale:66 YEARS
Population DistributionRural:64%Urban:36%
Per Capita Income:$ 1,372 P.A.DEMOGRAPHY
DEMOGRAPHY
DEMOGRAPHY
Major Hospitals:Nos. 965Teaching Hospitals:Nos. 64Dispensaries:Nos. 4,916Basic Health Units:Nos. 5,349Maternity Homes:Nos. 1,138Medical Colleges:Nos. 68Diabetic Care Centers:Nos. 200 approx.No. of Beds:109,005Ratio to Population:1 :1,575Registered Doctors:Nos. 137,956Ratio to Population:1 : 1,206No. of Dentists:9,462Ratio to Population:1 : 16,426No. of Nurses:68,387Ratio to Population:1 : 3,664No. of Nursing Schools:14Crude Birth Rate:24.3 / 1,000Crude Death Rate:6.8 / 1,000
Pakistans Healthcare Data Ref- MOH and Economic Survey of Pakistan.
Drug Price are officially controlled, Prices seized since 2000.Pakistans Pharma Market Data. Ref: 2012 - IMS Health Pakistan ( PKPI)Total No. Of Companies
811Total Pharmaceutical MarketRs. 175 B
US $1.9B
G.R 18%
MNC 23
National Pharma 788
Pakistans Pharma Market Data. Ref: 2012 - IMS Health Pakistan ( PKPI)
Premier Group of CompaniesPremier DistributorsPremier AgenciesPharmEvoZaman TextilesShield Corporation
8
US$ 50 million in 2005 to US$ 210 Million in 2011
Growth History - Group20052012
US$ 210 Million US$ 50 million (15% growth comes from existing account & rest from new accounts)
9
English Biscuits Mfg: Largest Biscuit / confectionary company in Pakistan, Group has 20% shareholding.
National Foods Ltd.: Largest package food company in Pakistan, 5% shareholding. Mr. Ebrahim Qassim is the board member of both the companies.
Mr. Haroon Qassim is the board member of English Biscuits Mfg.
GROUPs INVESTMENT
10
Committed Partnership
English Biscuits PF (in 1987 equity participation)197137 yearsNational Foods (in 1995 equity participation)197335 yearsSanofi Aventis197533 yearsMitchells1979 29 yearsShield Corporation Limited197929 yearsUnilever Pakistan - Rafhan Best Foods (1980 to 2008)28 yearsSearle (1973 to 1998)26 yearsBecton Dickinson198919 yearsToyo Nasic199315 yearsCadbury Pakistan198919 yearsAbbott Nutrition International 200008 years
PREMIER GROUP
11
PREMIER Distributors Consumer Division Since 1971
12
PREMIER AGENCIESPharma Division
13
Started its operation in 1985 Acquired by the group in 2003Leading manufacturers of export quality 100% cotton yarnExport regions include Asia, Africa, and South AmericaAggressive expansion plans in progress, planned for the next 3 years
Zaman Textiles
Started its operations in 1984
Over 30% market share in baby care products (feeders, soothers, nipples, and teethers) within the local market
Did Contract manufacturing for Gillette Pakistan for their Oral B and Contra lines of brushes until P&G took over.
Shield Corporation
Plant Karachi, Pakistan
PharmaceuticalsNutrition(Celia)Diagnostics(Omron)Healthcare Portfolio
PharmEvo Pvt. LtdBiotechnologyOncology
Other Rx
Diagnostics(Omron)
OMRON Corporation based in Japan since 1933, with a presence nearly all regions of the world.
Capital:$ 0.76 billion (March , 2010)Net Sales:$ 6.25 billion (March , 2010)
OMRON Group Employees: 36,299
Blood Pressure MonitorsDigital ThermometersBody Composition MonitorsPedometersNebulizerOthersProduct Lineup
Lactalis Worlds Largest Dairy / Nutritional based in France, with a presence nearly 150 countries.Nutrition(Celia)
Turn Over 11 billion EuroStaff36,500Industrial Sites125Collection9.2 Billion liters in the world
Pharmaceuticals
VISION
Our dream is to build a healthier society by becoming a leading and socially responsible global company through innovative solutions
Vision
Mission MISSION
Our mission is to be a global organization whose philosophy is characterized by a highly refined sense of ethics which is expressed tangibly through its dealings while upholding highest standards of integrity.
An organization that aspires to be a leader in providing quality healthcare solutions and where patients wellbeing is viewed as the ultimate concern.
Creates differentiation through pioneer ship in Cause Oriented Marketing.Cares for its employees, recognizes merit through rewards on achievements. Bears a progressive approach thereby encouraging initiatives, welcoming new ideas and always ready to move off the beaten track.Respects the hands that help relief pain and suffering.Embraces Information Technology as heart of the business and employs leading technologies to help achieve defined objectives.
Seeks to assure fair returns on investments through sustainability and growth
PharmEvo Private Limited
People More than1,000 people are working at PharmEvo to help save lives and improve quality of life Revenue17 Million USD in just 10 years.ProductsMarketing more than 112 variationsOf Pharmaceutical preparations
PharmEvo Private Limited
SystemPharmEvo is the 1st Pharmaceutical Company in Pakistan to have a complete BMS OTHERS: Integrated Management Systems (ISO 9000, ISO 14000 & ISO 18000)Partnership8 International Partners PharmEvo achieves success through close cooperation with partners who share a commonvision and complementary strengths.
Our Partners
POLAND
Becton Dickinson USA
PRC
Nanjing Aosaikang Medicinal Group, PRC
JAPAN
FRANCE
KOREA
Beijing Kawin Technology Share-Holding Co., Ltd PRC
PharmEvo Private Limited
VietnamMyanmarSri Lanka
Cambodia
Guatemala
Kenya
AfghanistanLocation Currently we operate in 9 Countries, with our headquarter in Karachi, Pakistan
Philippines
27
Markets under DevelopmentInternational OperationsExport Focus: Far East, Middle East & Africa, CIS, South America, EU Countries
PharmEvo Private Limited
MalaysiaTanzaniaYemen
Uzbekistan
Kazakhstan
28
HR Total group employees around 3,513DISTRIBUTION NETWORK 2,000 SKUs, 500 vans,14,00 Sales Personnel's, 8 visits a week to 25,000 30,000 pharmaciesTURNOVER Groups turnover is over Rs.18 Billion (US $210 Million)Our Strengths
PharmEvo Private Limited
29
RESEARCH One of the hallmarks of PharmEvos success is providing local clinical data to the medical community through Clinision Department MARKETING Has Positioned our company as an organization that goes beyond physical healthcare And has Established brands and Corporate imageQUALITY PharmEvos Success Story Starts from Quality Product, Which is maintained through our high professionals in Production Our Strengths
PharmEvo Private Limited
30
BUSINESS DEVELOPMENT &LICENSINGThroughStrategic Alliances, Portfolio Management & Developing New MarketsOur Strengths
PharmEvo Private Limited
(Pakistan Operations)Total PharmEvo Brand Sales from 2000 2011, 2012 Target (Rs.2,000 Million) = USD 24 Million
PharmEvos Ranking BY IMS Health, Pakistan.
1999 400th2012 31st
2006 70th
Total & PHARMEVO Sales trend over last 5 yearsPHARMEVORs. Mn PHARMEVO has an upward Sales in 3Q 2011, CAGR is 27.72% which is higher than Total Market and NationalsMKTCAGR 11 Vs 07TOTAL MKT. 15.89%NATIONAL18.05%PHARMEVO 27.72%
3rd Qtr 2011
% PHARMEVO has shown better growth in 3Q 2011 as compared to same period last year 3rd Qtr 2011Total & PHARMEVO Growth trend over last 4 years
% PHARMEVO has shown better growth in 3Q 2011 as compared to same period last year 3rd Qtr 2011Total & PHARMEVO Unit Growth trend over last 4 years
Earning Award of Excellence
PharmEvos Products in Therapeutic Segments BIO-TECHHYPOLIPIDAEMICANTI-PEPTIC ULCERANTANTI-INFECTIVE / ANTIBIOTICANTI-HISTAMINICANTI-PLATELET AGGREGATORANALGESICSBONE CALCIUM REGULATORANTI-OBESITYANABOLIC / HAEMATOPOETICSANTI-EPILEPTICIRON-PREPARATIONANTI-PSYCHOTICANTI-HYPERTENSIVEANTI-DIABETICNUTRITIONDIAGNOSTICSANTI-NEOPLASTICSANTI-RHEUMATOLOGICALS
At PharmEvo we have infrastructure and expertise to conduct PHASE-II - IV clinical studies At present we are highly engaged / involved in Phase IV clinical trialsOne of the hallmarks of PharmEvos success is providing local clinical data to the medical communityUp till now we have conducted clinical trials on local population in Cardiovascular, Diabetes, Analgesic & Anti-Infective segments
Marketing Strategies Medical Involvement
Aggressive Promotion
Skilled Sales ForceAchieveCustomer Satisfaction
Marketing Philosophy / ActivitiesUnique Books publication and distributionThematic calendars since 2000Sponsoring Digital libraries in large hospitals and medical schoolsRewards and Incentives to Medical StudentsLocal User TrialsVideo ShowsSkill development opportunities for medical professionalsCareer guidance workshops for young students
Statistical and Training Services Provided by ClinisionTotal 245 Statistical services requests completed
Research Data Compiling Training Services Provided to Doctors by Clinision- A PharmEvos DivisionTotal Doctors Trained so Far 1,932
International CSR Activities
Symposium Organized At Cambodia
National Activities
Pakistan Chest Society
Manufacturer
National Distributor/Company's Own distribution
Dispensing DoctorsRetailer
Wholesaler
Govt./Pvt.Hospitals/Clinics
Consumer
Preferred Dealers
Cytotoxic drugsNormal
Distribution Network
Manufacturing Facility Overview10 Acre Facility, Michael Taylor ConsultantModernized Manufacturing Facility As Per GMP & FDA RequirementsIMS accreditation (ISO 9001:2000-QMS), (ISO 14001:2004-EMS) & (ISO 18001:2000_OHSAS).Completely Separate Buildings For Cephalosporin & Non-Cephalosporin Products As Per WHO Guidelines
Manufacturing Facility
Manufacturing Facility Expansion Plan
Main Features Dedicated building for the formulation of Cephalosporin21 Air handling units installed in operational areas
Building Management System (BMS) from Honeywell
SectionsCapsule SectionTablet SectionOral liquid SectionOintment Section WarehousePackaging Quality AssuranceTotal Production area - 16,000 Sq. Ft.
Production Area Main BuildingNon-Sensitive Pharmaceuticals
SectionsCapsule SectionTablet SectionDry Powder SuspensionComponents washing & sterilization Sterile Injection SectionPackaging SectionMaterial Handling SectionTotal Production area 9,000 Sq. Ft.
Production Area Cephalosporin's
Quality Assurance
No Compromise On Quality ZERO TOLERANCE POLICY
Fully Equipped Laboratory
Latest Equipment's For Complete Analysis Of Products
PharmEvo is the first pharmaceutical company in Pakistan to have a complete BMS.
Building Management System -BMS
Online Monitoring & Control Of
Manufacturing room parametersAir Flow & VolumeRelative HumidityAir Handling UnitsAir Filtration SystemHEPA Filter Performance For GMP Compliance
Manufacturing As Per Pharmacopeial Specifications.
Salient features - BMS
BMS-Main Page
BMS-System Architecture
BMS-Power Operation Monitoring
BMS-AHU Status on Main Building
BMS-AHU Monitoring & Control
Thank you !BMS-Water System Monitoring & Control
OrganogramBOARD OF DIRECTORS:Ebrahim QassimGroup ChairmanDerek EvansChairman PharmEvoM. Haroon QassimManaging DirectorZamiruddin AhmedDirector
Ebrahim Qassim (Group Chairman)Chartered Accountant40 years of experience ranging from Pharmaceuticals, Distribution, and Textiles to Consumer GoodsServed on many professional organizations, including KSE, ICAP, MAP, etc.A renowned and respected industrialist
Derek Alan Evans (Chairman PharmEvo)Derek joined Searle in 1963 and served until 1987 when he retired as Vice President for Searle operation in Europe.Appointment in National Health Service (NHS) of the West London Health Authority in 1998.Chairman of Stoke Mandeville Hospital which is the largest paraplegic hospital in Europe from which he retired in 2005
Key Personnel
M. Haroon Qassim (Managing Director)
CPA and MBA (USA)17 years of experience ranging from Distribution & Finance to Pharmaceuticals.Ex-Chairman Pakistan Pharmaceutical Manufacturers Association. ( PPMA )
Dr. Munir Anwar (Director Technical )
MBA, PhD in Pharmacognosy from University of Karachi32 years experience in Pharmaceutical Manufacturing
Key Personnel (Continued..)
S. Jamshed Ahmad (Director Marketing& Sales)
B. Pharm, MBA Pharmaceutical Marketing USA. 17 Years Experience in Pharmaceutical Marketing
M. Nadeem Rehmat (Director Business Development)
B.Pharm, MBAOver 17 years of experience in Pharmaceutical Industry / Business Development
Key Personnel (Continued..)
What Pakistan Offers?A Positive Shift In Perception Of Doctors Towards National CompaniesHigh-Quality Human ResourcesAuxiliary Industries EstablishedEasy Access To CIS (Central independent State)
What PharmEvo Offers?700+Medical RepsIn PakistanMost Credible Corporate ImageExpertise InTop 8 Therapeutic Categories Business Ethics & Knowledge Based PhilosophyAggressive & Responsive CultureEnsured Quality
What Are We Looking For?
THANK U.
Chart10.360.270.290.70000000010.28
100%% Urban Population Out of Total Population
Sheet1PakistanBangladeshIndiaMalaysiaVietnam100%36%27%29%70%0.28
Chart18377
10%Physician Per 10,000 Population6
Sheet1PakistanBangladeshIndiaMalaysia10%800%300%700%700%
Chart112.5455380165250380507670900100014502000
TotalTarget 2,000
Sheet12000200120022003200420052006200720082009201020112012Total12.5455380165250380507670900100014502000
Chart189449256804465102022994985923701000585227165344892173267209584211885521851964697015811884523539135013402269735874023771040661257161357804072901978618481326706368
TotalNATIONALPHARMEVO
Sheet120072008200920102011Total89,449,256,804100,058,522,716118,855,218,519135,013,402,269161,357,804,072NATIONAL46,510,202,29953,448,921,73264,697,015,81173,587,402,37790,197,861,848PHARMEVO498,592,370672,095,842884,523,5391,040,661,2571,326,706,368
Chart111.8614.9234.818.7921.0431.6113.5913.7417.6519.5122.5727.49
TotalNATIONALPHARMEVOYears
Sheet1Years2008200920102011Total11.8618.7913.5919.51NATIONAL14.9221.0413.7422.57PHARMEVO34.8031.6117.6527.49
Chart16.277.7425.7710.9412.8823.855.956.458.0110.7814.3215.28
TotalNATIONALPHARMEVOYears
Sheet1Years2008200920102011Total6.2710.945.9510.78NATIONAL7.7412.886.4514.32PHARMEVO25.7723.858.0115.28